Viewing Study NCT06434467


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-01-10 @ 3:23 PM
Study NCT ID: NCT06434467
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-30
First Post: 2024-05-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module